Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Worcester. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Worcester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy of for Mirvetuximab Soravtansine in participants with platinum-resistant advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer (platinum-resistant ovarian cancer) (PROC) whose tumors express a high level of folate receptor alpha (FRα). Mirvetuximab Soravtansine (MIRV) is an investigational antibody drug conj
Sponsor: AbbVie
Check if you qualify for this ovarian cancer clinical trial in Worcester, MA
If you're searching for ovarian cancer treatment options in Worcester, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Worcester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.